Leveraging incentives to increase HIV testing uptake among men: qualitative insights from rural Uganda.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
30 Dec 2019
Historique:
received: 01 03 2019
accepted: 11 12 2019
entrez: 1 1 2020
pubmed: 1 1 2020
medline: 18 3 2020
Statut: epublish

Résumé

Few studies have explored how economic incentives influence behavioral outcomes. This study aimed to identify pathways of action of an incentives-based intervention to increase men's participation in HIV testing. The qualitative study was embedded in a randomized-controlled trial that compared effectiveness of gain-framed, loss-framed and lottery-based incentives to increase HIV testing among men. Following testing at a community health campaign, 60 in-depth interviews were conducted with men systematically sampled on the basis of age, incentive group, and campaign attendance. Data were coded deductively and inductively for thematic content analysis. Incentives addressed men's structural, interpersonal and individual-level barriers to testing: offered at convenient locations, incentives offset costs of testing, in lost wages, which are exacerbated when livelihoods required mobility. Interpersonal barriers included anticipated stigma/fear of disclosure, social obligations, and negative peer influences. Providing incentives in public settings provided "social proof" that prizes could be won, and facilitated social support and positive norms by promoting testing with trusted others. Incentives had little influence when men appraised prize values to be low, disbelieved they would win a prize, or were already intrinsically motivated to test. Yet, incentives provided a behavioral 'cue to action' for many men who perceived themselves to be susceptible to HIV and perceived HIV disease to be severe, acting as secondary motivator for testing that "sweetened the deal". Incentives can be an important 'lever' to promote men's healthy behaviors in resource-poor settings. HIV testing in convenient, public settings, when paired with incentives, provides multiple pathways to stimulate men's testing uptake. Registered with ClinicalTrials.gov on 08/10/2016, ID: NCT02890459. The first participant was enrolled on 11th April 2016.

Sections du résumé

BACKGROUND BACKGROUND
Few studies have explored how economic incentives influence behavioral outcomes. This study aimed to identify pathways of action of an incentives-based intervention to increase men's participation in HIV testing.
METHODS METHODS
The qualitative study was embedded in a randomized-controlled trial that compared effectiveness of gain-framed, loss-framed and lottery-based incentives to increase HIV testing among men. Following testing at a community health campaign, 60 in-depth interviews were conducted with men systematically sampled on the basis of age, incentive group, and campaign attendance. Data were coded deductively and inductively for thematic content analysis.
RESULTS RESULTS
Incentives addressed men's structural, interpersonal and individual-level barriers to testing: offered at convenient locations, incentives offset costs of testing, in lost wages, which are exacerbated when livelihoods required mobility. Interpersonal barriers included anticipated stigma/fear of disclosure, social obligations, and negative peer influences. Providing incentives in public settings provided "social proof" that prizes could be won, and facilitated social support and positive norms by promoting testing with trusted others. Incentives had little influence when men appraised prize values to be low, disbelieved they would win a prize, or were already intrinsically motivated to test. Yet, incentives provided a behavioral 'cue to action' for many men who perceived themselves to be susceptible to HIV and perceived HIV disease to be severe, acting as secondary motivator for testing that "sweetened the deal".
CONCLUSION CONCLUSIONS
Incentives can be an important 'lever' to promote men's healthy behaviors in resource-poor settings. HIV testing in convenient, public settings, when paired with incentives, provides multiple pathways to stimulate men's testing uptake.
TRIAL REGISTRATION BACKGROUND
Registered with ClinicalTrials.gov on 08/10/2016, ID: NCT02890459. The first participant was enrolled on 11th April 2016.

Identifiants

pubmed: 31888589
doi: 10.1186/s12889-019-8073-6
pii: 10.1186/s12889-019-8073-6
pmc: PMC6937741
doi:

Banques de données

ClinicalTrials.gov
['NCT02890459']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1763

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH105254
Pays : United States
Organisme : Foundation for the National Institutes of Health
ID : 5R01MH105254-04

Références

Health Educ Q. 1990 Spring;17(1):53-72
pubmed: 2318652
AIDS Care. 2016;28 Suppl 3:67-73
pubmed: 27421053
Annu Rev Psychol. 2001;52:1-26
pubmed: 11148297
Lancet Glob Health. 2017 Sep;5(9):e847-e848
pubmed: 28807171
N Engl J Med. 2009 Feb 12;360(7):699-709
pubmed: 19213683
BMJ. 2010 May 17;340:c2220
pubmed: 20478960
JAMA. 2007 Oct 24;298(16):1900-10
pubmed: 17954541
SAHARA J. 2014;11:116-25
pubmed: 25023208
AIDS. 2018 Jul 17;32(11):1443-1451
pubmed: 29683850
Health Educ Q. 1984 Spring;11(1):1-47
pubmed: 6392204

Auteurs

Alex Ndyabakira (A)

Infectious Diseases Research Collaboration, Kampala, Uganda. ndyabakira@gmail.com.

Monica Getahun (M)

Department of Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA.

Ambrose Byamukama (A)

Infectious Diseases Research Collaboration, Kampala, Uganda.

Devy Emperador (D)

Department of Medicine, Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA, USA.

Stella Kabageni (S)

Infectious Diseases Research Collaboration, Kampala, Uganda.

Kara Marson (K)

Department of Medicine, Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA, USA.

Dalsone Kwarisiima (D)

Infectious Diseases Research Collaboration, Kampala, Uganda.

Gabriel Chamie (G)

Department of Medicine, Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA, USA.

Harsha Thirumurthy (H)

Division of Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, PA, USA.

Diane Havlir (D)

Department of Medicine, Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA, USA.

Moses R Kamya (MR)

School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

Carol S Camlin (CS)

Department of Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH